Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]
Amgen's Phase 2 trial of Efavaleukin Alfa for moderately to severely active ulcerative colitis was terminated. Safety and efficacy results h…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Peer Mentoring to Improve Self-management in Youth With IBD [NA]
A trial evaluating peer mentoring to improve self-management in youth with Crohn's disease and ulcerative colitis has been terminated, with …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis [Phase 2]
Phase 2 trial update for MARVEL evaluating a mitochondrial antioxidant therapy to resolve inflammation in Ulcerative Colitis; the study is a…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Comparative Accuracy of Activity Scores of Intestinal Ultrasound and Colonoscopy in Monitoring Ulcerative Colitis Activity
This clinical trial assesses the accuracy of AssessIUS intestinal ultrasound compared with colonoscopy for monitoring ulcerative colitis act…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Effects of Gluten Free Diet in Ulcerative Colitis [NA]
A completed clinical trial evaluated the effects of a gluten-free diet in ulcerative colitis at the University of Southern Denmark.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Micronutrient and Additive Modifications May Optimize Diet To Health [NA]
A clinical trial in Region Skane is actively recruiting to test whether micronutrient and additive modifications to the diet can improve hea…
-
CLINICAL_TRIALS other · 2026-01-12Clinical Trial Update: A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) [Phase 3]
This entry describes an ongoing Phase 3 study evaluating the long-term safety and efficacy of Upadacitinib in Ulcerative Colitis. The trial …
-
CLINICAL_TRIALS withdrawal · 2026-01-09Clinical Trial Update: Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis [Phase 2]
Phase 2 clinical trial Mini-MARVEL evaluating a mitochondrial antioxidant therapy for ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Exploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome Disability [NA]
A completed University of Pennsylvania trial evaluated multiple self-help interventions designed to boost self-efficacy and reduce disabilit…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease [NA]
This clinical trial update notes the completion of a self-management intervention study for individuals with inflammatory bowel disease, inc…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Gluten-free Diet in PSC and IBD [NA]
Clinical trial update describing an active-not-recruiting study evaluating a gluten-free diet in people with primary sclerosing cholangitis …
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's Disease
This clinical trial update reports the completion of a study evaluating upadacitinib for disease activity and safety in adults with ulcerati…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC) [NA]
A clinical trial update shows a study evaluating hyperbaric oxygen therapy for ulcerative colitis is currently recruiting at Northwestern Un…
-
FDA approval · 2026-01-07FDA Approved: YESINTEK — Supplemental Application (Biocon Biologics Inc.)
The FDA approved a supplemental application for YESINTEK (ustekinumab) from Biocon Biologics Inc. The action relates to the ustekinumab bios…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Predicting Biologic Therapy Success in Ulcerative Colitis Using Intestinal Ultrasound and Fat Assessment
A clinical trial update from Assiut University describes a study to predict biologic therapy success in ulcerative colitis using intestinal …
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications [Phase 4]
This Phase 4 update reports outcomes from hyperbaric oxygen therapy across several emerging indications, with the study currently not yet re…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Novel Biomarkers in Inflammatory Bowel Disease
A completed clinical trial evaluating novel biomarkers in inflammatory bowel diseases (including Crohn's disease and ulcerative colitis), sp…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: CEDUR - German IBD Registry
Clinical trial update for the CEDUR German IBD Registry shows recruitment for ulcerative colitis, indeterminate colitis, and Crohn's disease…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease [NA]
A completed clinical trial evaluated switching adult inflammatory bowel disease patients from intravenous to subcutaneous infliximab.
-
CLINICAL_TRIALS other · 2026-01-02Clinical Trial Update: Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics [Phase 2]
Phase 2 clinical trial evaluating ALTB-268 for efficacy and safety in moderately to severely active ulcerative colitis patients refractory t…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Study on the Use of Traditional Chinese Medicine Diagnostic Tools to Assist in Identifying the Clinical Characteristics of Inflammatory Bowel Disease and Research on Metabolic Plastids of Tongue Coating
This entry notes that a recruiting clinical trial from China Medical University Hospital is examining traditional Chinese medicine diagnosti…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis [Phase 3]
Results from an extension Phase 3 study of RPC1063 for moderate-to-severe ulcerative colitis have been completed and posted. The study is sp…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis
This ClinicalTrials.gov entry describes an ongoing study at Xijing Hospital investigating sleep disorders in patients with Ulcerative Coliti…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Japan
This report covers the completion of an observational study in Japan evaluating changes in Ulcerative Colitis disease activity and adverse e…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease [EARLY_Phase 1]
An early-phase trial evaluating a universal CAR-T cell therapy targeting CD19 and BCMA for moderate-to-severe ulcerative colitis and Crohn's…